RT Journal Article SR Electronic T1 Reply: Advantages and Limits of Targeted Radionuclide Therapy with Somatostatin Antagonists JF Journal of Nuclear Medicine JO J Nucl Med FD Society of Nuclear Medicine SP 547 OP 548 DO 10.2967/jnumed.117.203703 VO 59 IS 3 A1 Guillaume P. Nicolas A1 Damian Wild A1 Melpomeni Fani YR 2018 UL http://jnm.snmjournals.org/content/59/3/547.abstract AB